{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T14:31:25Z","timestamp":1761489085531,"version":"3.37.3"},"reference-count":29,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2013,5,1]],"date-time":"2013-05-01T00:00:00Z","timestamp":1367366400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,5,1]],"date-time":"2013-05-01T00:00:00Z","timestamp":1367366400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["dmd.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug Metabolism and Disposition"],"published-print":{"date-parts":[[2013,5]]},"DOI":"10.1124\/dmd.112.050450","type":"journal-article","created":{"date-parts":[[2013,2,20]],"date-time":"2013-02-20T05:43:14Z","timestamp":1361338994000},"page":"1023-1034","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Contribution of Artifacts to N-Methylated Piperazine Cyanide Adduct Formation In Vitro from N-Alkyl Piperazine Analogs"],"prefix":"10.1016","volume":"41","author":[{"given":"Minli","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christina M.","family":"Resuello","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jian","family":"Guo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark E.","family":"Powell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charles S.","family":"Elmore","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karthick","family":"Vishwanathan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1124\/dmd.112.050450_bib1","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1021\/co300105t","article-title":"Efficient catalyst-free four-component synthesis of novel \u03b3-aminoethers mediated by a Mannich type reaction","volume":"15","author":"Abonia","year":"2012","journal-title":"ACS Comb Sci"},{"key":"10.1124\/dmd.112.050450_bib2","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1021\/tx0501637","article-title":"Cyanide trapping of iminium ion reactive intermediates followed by detection and structure identification using liquid chromatography-tandem mass spectrometry (LC-MS\/MS)","volume":"18","author":"Argoti","year":"2005","journal-title":"Chem Res Toxicol"},{"key":"10.1124\/dmd.112.050450_bib3","doi-asserted-by":"crossref","first-page":"1966","DOI":"10.1124\/dmd.112.047027","article-title":"High-resolution mass spectrometry elucidates metabonate (false metabolite) formation from alkylamine drugs during in vitro metabolite profiling","volume":"40","author":"Barbara","year":"2012","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.112.050450_bib4","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1007\/s004200050228","article-title":"Time-resolved cutaneous absorption and permeation rates of methanol in human volunteers","volume":"70","author":"Batterman","year":"1997","journal-title":"Int Arch Occup Environ Health"},{"key":"10.1124\/dmd.112.050450_bib5","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1124\/dmd.108.020545","article-title":"Comparison of the bioactivation potential of the antidepressant and hepatotoxin nefazodone with aripiprazole, a structural analog and marketed drug","volume":"36","author":"Bauman","year":"2008","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.112.050450_bib6","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/S0021-9258(18)55950-0","article-title":"The reaction of pyridine nucleotide with cyanide and its analytical use","volume":"191","author":"Colowick","year":"1951","journal-title":"J Biol Chem"},{"key":"10.1124\/dmd.112.050450_bib7","first-page":"1","article-title":"Effects of methanol vapor on human neurobehavioral measures","volume":"42","author":"Cook","year":"1991","journal-title":"Res Rep Health Eff Inst"},{"key":"10.1124\/dmd.112.050450_bib8","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1021\/tx034170b","article-title":"Drug-protein adducts: an industry perspective on minimizing the potential for drug bioactivation in drug discovery and development","volume":"17","author":"Evans","year":"2004","journal-title":"Chem Res Toxicol"},{"key":"10.1124\/dmd.112.050450_bib9","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1080\/004982597240541","article-title":"Recognition of novel artifacts produced during the microsomal incubation of secondary alicyclic amines in the presence of cyanide","volume":"27","author":"Gorrod","year":"1997","journal-title":"Xenobiotica"},{"key":"10.1124\/dmd.112.050450_bib10","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1007\/BF03188923","article-title":"The metabolism of alicyclic amines to reactive iminium ion intermediates","volume":"19","author":"Gorrod","year":"1994","journal-title":"Eur J Drug Metab Pharmacokinet"},{"key":"10.1124\/dmd.112.050450_bib11","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.yrtph.2004.05.001","article-title":"The implausibility of leukemia induction by formaldehyde: a critical review of the biological evidence on distant-site toxicity","volume":"40","author":"Heck","year":"2004","journal-title":"Regul Toxicol Pharmacol"},{"key":"10.1124\/dmd.112.050450_bib12","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1517\/17425255.1.1.91","article-title":"Minimising the potential for metabolic activation in drug discovery","volume":"1","author":"Kalgutkar","year":"2005","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"10.1124\/dmd.112.050450_bib13","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1038\/nrd1750","article-title":"Idiosyncratic drug hepatotoxicity","volume":"4","author":"Kaplowitz","year":"2005","journal-title":"Nat Rev Drug Discov"},{"key":"10.1124\/dmd.112.050450_bib14","first-page":"43","article-title":"Minimizing metabolic activation during pharmaceutical lead optimization: progress, knowledge gaps and future directions","volume":"11","author":"Kumar","year":"2008","journal-title":"Curr Opin Drug Discov Devel"},{"key":"10.1124\/dmd.112.050450_bib15","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1124\/dmd.105.008367","article-title":"Identification of a novel in vitro metabonate from liver microsomal incubations","volume":"34","author":"Li","year":"2006","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.112.050450_bib16","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1124\/dmd.112.044917","article-title":"Reaction of homopiperazine with endogenous formaldehyde: a carbon hydrogen addition metabolite\/product identified in rat urine and blood","volume":"40","author":"Martin","year":"2012","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.112.050450_bib17","doi-asserted-by":"crossref","first-page":"2796","DOI":"10.1016\/S0021-9258(19)44077-5","article-title":"Enzymatic oxidation of nicotine to nicotine 1\u2032(5\u2032) iminium ion. A newly discovered intermediate in the metabolism of nicotine","volume":"248","author":"Murphy","year":"1973","journal-title":"J Biol Chem"},{"key":"10.1124\/dmd.112.050450_bib18","doi-asserted-by":"crossref","first-page":"4896","DOI":"10.1021\/jm300065h","article-title":"Mechanism-based inactivation (MBI) of cytochrome P450 enzymes: structure-activity relationships and discovery strategies to mitigate drug-drug interaction risks","volume":"55","author":"Orr","year":"2012","journal-title":"J Med Chem"},{"key":"10.1124\/dmd.112.050450_bib19","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1002\/rcm.5005","article-title":"Characterization of cyanide-trapped methylated metabonates formed during reactive drug metabolite screening in vitro","volume":"25","author":"Rousu","year":"2011","journal-title":"Rapid Commun Mass Spectrom"},{"key":"10.1124\/dmd.112.050450_bib20","first-page":"106","article-title":"The role of iminium-enamine species in the toxication and detoxication of cyclic tertiary amines","volume":"173","author":"Sayre","year":"1997","journal-title":"NIDA Res Monogr"},{"key":"10.1124\/dmd.112.050450_bib21","doi-asserted-by":"crossref","first-page":"873","DOI":"10.2174\/138920006779010629","article-title":"Reaction of primary and secondary amines to form carbamic acid glucuronides","volume":"7","author":"Schaefer","year":"2006","journal-title":"Curr Drug Metab"},{"key":"10.1124\/dmd.112.050450_bib22","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.reprotox.2003.10.013","article-title":"NTP-CERHR expert panel report on the reproductive and developmental toxicity of methanol","volume":"18","author":"Shelby","year":"2004","journal-title":"Reprod Toxicol"},{"key":"10.1124\/dmd.112.050450_bib23","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1021\/tx800415j","article-title":"Metabolites in safety testing (MIST): considerations of mechanisms of toxicity with dose, abundance, and duration of treatment","volume":"22","author":"Smith","year":"2009","journal-title":"Chem Res Toxicol"},{"key":"10.1124\/dmd.112.050450_bib24","first-page":"1239","article-title":"Diarylborinic acid derivatives as a catalytic iminium ion generator in the mannich-type reaction using secondary amines, aldehydes, and ketene silyl acetals","volume":"8","author":"Tanaka","year":"2008","journal-title":"Synlett"},{"key":"10.1124\/dmd.112.050450_bib25","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1088\/0967-3334\/27\/7\/007","article-title":"A longitudinal study of methanol in the exhaled breath of 30 healthy volunteers using selected ion flow tube mass spectrometry, SIFT-MS","volume":"27","author":"Turner","year":"2006","journal-title":"Physiol Meas"},{"key":"10.1124\/dmd.112.050450_bib26","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1016\/0006-291X(74)90319-2","article-title":"NADPH-dependent oxidation of methanol, ethanol, propanol and butanol by hepatic microsomes","volume":"60","author":"Teschke","year":"1974","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1124\/dmd.112.050450_bib27","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1146\/annurev.med.58.072905.160823","article-title":"Idiosyncratic toxicity: a convergence of risk factors","volume":"58","author":"Ulrich","year":"2007","journal-title":"Annu Rev Med"},{"key":"10.1124\/dmd.112.050450_bib28","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1080\/10408440590935620","article-title":"Role of metabolism in drug-induced idiosyncratic hepatotoxicity","volume":"35","author":"Walgren","year":"2005","journal-title":"Crit Rev Toxicol"},{"key":"10.1124\/dmd.112.050450_bib29","first-page":"59","article-title":"Idiosyncratic toxicity: mechanistic insights gained from analysis of prior compounds","volume":"8","author":"Waring","year":"2005","journal-title":"Curr Opin Drug Discov Devel"}],"container-title":["Drug Metabolism and Disposition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090955624115814?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090955624115814?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/dmd.112.050450","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,18]],"date-time":"2025-02-18T19:40:25Z","timestamp":1739907625000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090955624115814"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,5]]},"references-count":29,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2013,5]]}},"alternative-id":["S0090955624115814"],"URL":"https:\/\/doi.org\/10.1124\/dmd.112.050450","relation":{},"ISSN":["0090-9556"],"issn-type":[{"type":"print","value":"0090-9556"}],"subject":[],"published":{"date-parts":[[2013,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Contribution of Artifacts to N-Methylated Piperazine Cyanide Adduct Formation In Vitro from N-Alkyl Piperazine Analogs","name":"articletitle","label":"Article Title"},{"value":"Drug Metabolism and Disposition","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/dmd.112.050450","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2012 by The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}